Edward A. Hatfield

Nov 5, 2024 | ajp.com.au | Megan Haggan |Kelly Abbott |Edward A. Hatfield |Sheshtyn Paola

The AJP asked readers whether their pharmacies were stocking vapes – and the response was overwhelmingly negative As reported by the AJP, the issue of selling over-the-counter vapes has been contentious since its last-minute announcement before legislation was passed in June 2024. Last month (October 2024) we reported on reader comments around the issue, asThis content is restricted to registered users only.

Nov 5, 2024 | ajp.com.au | Nicholas O’Donoghue |Kelly Abbott |Edward A. Hatfield |Debbie Rigby

Medicines “ruined” after extreme weather event takes out Transgrid powerline  Thousands of dollars’ worth of medications has been lost after thieves stole a backup power generator from a Broken Hill pharmacy.   Jason Harvey, a partner in the Outback Pharmacies group, which operates five stores in Broken Hill, told local media that a generator providedThis content is restricted to registered users only.

Nov 5, 2024 | ajp.com.au | Sheshtyn Paola |Kelly Abbott |Edward A. Hatfield |Debbie Rigby

Nearly four in five women may not be using effective contraception while taking teratogenic medications, a study examining PBS medicines dispensing has uncovered A new study has found low rates of highly effective hormonal contraceptive overlap among women dispensed teratogenic medications and pharmacists are in a crucial position to intervene, says its lead author. TheThis content is restricted to registered users only.

Nov 5, 2024 | ajp.com.au | Kelly Abbott |Edward A. Hatfield |Debbie Rigby |Sheshtyn Paola

It’s vital to keep your finger on the pulse when it comes to consultant pharmacy, especially with changes to aged care, says one sector veteran – and what about pay? AJP Podcast host Carlene McMaugh speaks with Dr Jenny Gowan, an industry stalwart and long-time AJP contributor who was honoured with the Member of theThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Nov 5, 2024 | ajp.com.au | Nicholas O’Donoghue |Kelly Abbott |Edward A. Hatfield |Debbie Rigby

Government says 'no', to lifting ban on compounding glucagon-like peptide-1 receptor agonists (GLP-1 RAs)  Risks associated with compounded GLP-1 RAs outweigh the benefits of improved access to the medication, Mark Butler the Minister for Health and Aged Care says. Responding to a petition calling on the government to establish an approval mechanism for compounded semaglutideThis content is restricted to registered users only.